(Q38833700)

6 September 2017

title

HEPACAM inhibited the growth and migration of cancer cells in the progression of non-small cell lung cancer (English)

1 reference

6 September 2017

1 reference

Huanzhang Shao

1

1 reference

6 September 2017

Yinjie Gu

2

1 reference

6 September 2017

Junli Ding

3

1 reference

6 September 2017

Peihua Lu

4

1 reference

6 September 2017

Tingyan Ruan

5

1 reference

6 September 2017

Wenbin Lu

6

1 reference

6 September 2017

publication date

22 September 2015

1 reference

6 September 2017

1 reference

6 September 2017

volume

37

1 reference

6 September 2017

issue

2

1 reference

6 September 2017

page(s)

2621-2627

1 reference

6 September 2017

cites work

Cancer statistics, 2015

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4084-9

Choroidal metastasis response to crizotinib in a ROS1-rearranged NSCLC patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4084-9

The clinicopathological significance and potential drug target of E-cadherin in NSCLC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4084-9

Biomarker discovery in non-small cell lung cancer: integrating gene expression profiling, meta-analysis, and tissue microarray validation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4084-9

The expression and modulation of CEACAM1 and tumor cell transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4084-9

Functional analyses of mutations in HEPACAM causing megalencephalic leukoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4084-9

Identification of hypermethylation in hepatocyte cell adhesion molecule gene promoter region in bladder carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4084-9

Expression of hepaCAM is downregulated in cancers and induces senescence-like growth arrest via a p53/p21-dependent pathway in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4084-9

HEPN1, a novel gene that is frequently down-regulated in hepatocellular carcinoma, suppresses cell growth and induces apoptosis in HepG2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4084-9

HepaCAM inhibits clear cell renal carcinoma 786-0 cell proliferation via blocking PKCε translocation from cytoplasm to plasma membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4084-9

The immunoglobulin-like cell adhesion molecule hepaCAM induces differentiation of human glioblastoma U373-MG cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4084-9

Expression and clinical significance of hepaCAM and VEGF in urothelial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4084-9

The roles of cell adhesion molecules in tumor suppression and cell migration: a new paradox

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4084-9

The immunoglobulin-like cell adhesion molecule hepaCAM is cleaved in the human breast carcinoma MCF7 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4084-9

Cloning and characterization of hepaCAM, a novel Ig-like cell adhesion molecule suppressed in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4084-9

Overexpression of HepaCAM inhibits cell viability and motility through suppressing nucleus translocation of androgen receptor and ERK signaling in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4084-9

Inhibition of β-Catenin enhances the anticancer effect of irreversible EGFR-TKI in EGFR-mutated non-small-cell lung cancer with a T790M mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4084-9

Zbed3 contributes to malignant phenotype of lung cancer via regulating β-catenin and P120-catenin 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4084-9

Wnt/β-catenin signaling and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4084-9

Reduced expression of the chromatin remodeling gene ARID1A enhances gastric cancer cell migration and invasion via downregulation of E-cadherin transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4084-9

Cyr61 is overexpressed in gliomas and involved in integrin-linked kinase-mediated Akt and beta-catenin-TCF/Lef signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4084-9

GlialCAM, a glial cell adhesion molecule implicated in neurological disease.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26392113

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S13277-015-4084-9

1 reference

Dimensions Publication ID

6 September 2017

1050096429

0 references

1 reference